期刊文献+

缩宫素受体在子宫内膜异位症子宫结合带中的表达 被引量:12

The expression of oxytocin receptor in uterine junctional zone of women with endometriosis
原文传递
导出
摘要 目的探讨缩宫素受体(OTR)在子宫内膜异位症(EMS)子宫结合带中的表达水平及临床意义。方法收集因EMS行子宫切除术的子宫结合带蜡块组织43例为EMS组,其中增生期25例,分泌期18例。收集同期因宫颈癌、卵巢癌或宫颈上皮内瘤变Ⅲ级行子宫切除术的患者子宫结合带蜡块组织54例为对照组,其中增生期28例,分泌期26例。采用免疫组织化学方法检测各组子宫结合带组织中OTR的表达水平。结果对照组增生期子宫结合带OTR(0.156±0.056)表达高于分泌期子宫结合带OTR(0.126±0.030),差异有统计学意义(P=0.017)。EMS组增生期(0.205±0.106)和分泌期(0.187±0.070)子宫结合带OTR含量表达无统计学差异(P=0.523),且含量分别高于对照组(0.156±0.056,0.126±0.030)相应月经周期子宫结合带OTR的表达,差异均有统计学意义(P=0.043,P=0.002)。EMS组子宫结合带中OTR的表达水平与痛经程度呈正相关(r=0.836,P<0.05)。结论 EMS子宫结合带缩宫素受体异常高表达,表明其可能和EMS的发病及引起的相关症状有关。 ObjectiveTo explore the expression and clinical significance of oxytocin receptor (OTR) in the junctional zone (JZ) in women with endometriosis (EMS).MethodsForty-three patients with EMS (including 25 cases in proliferative phase and 18 cases in secretory phase) undergoing hysterectomy were selected as EMS group. The tissues of uterine JZ were obtained. In the meantime, 54 patients (including 28 cases in proliferative phase and 26 cases in secretory phase) with cervical carcinoma, ovarian cancer or cervical intraepithelial neoplasia were selected as control group. Immunohistochemistry technique was used to detect the protein expression of OTR in the uterine JZ with and without EMS.ResultsIn control group, the OTR expression of the uterine junctional in proliferative group was 0.156±0.056, which was significantly higher than that of secretory phase (0.126±0.030) (P=0.017). In EMS group, the difference of the OTR expression of the uterine JZ between the proliferative phase (0.205±0.106) and secretory phase (0.187±0.070) had no statistical significance (P=0.523). The expressions of OTR in the uterine JZ of proliferative phase of EMS group and control group (0.156±0.056) showed a significant difference (P=0.043). Similarly, the OTR expression in the uterine JZ of secretory phase was significantly higher than that (0.126±0.030) of control group (P=0.002). The expression level of OTR in the uterine JZ of women with EMS is positively correlated with the degree of dysmenorrhea (r=0.836, P〈0.05).ConclusionThe higher expression of OTR in the uterine JZ of EMS might be associated with pathogenesis and related symptoms of EMS.
作者 黄苗苗 何晔 李绪清 郭培培 许孝凤 魏兆莲 Huang Miaomiao He Ye Li Xuqing Guo Peipei Xu Xiaofeng Wei Zhaolian(Department of Gynecology and Obstetrics, the First Affiliated Hospital of Anhui Medical University, Hefei 230000, Chin)
出处 《中华生殖与避孕杂志》 CAS CSCD 北大核心 2017年第3期203-207,共5页 Chinese Journal of Reproduction and Contraception
基金 安徽高校自然科学研究任务项目(KJ2015A056)~~
关键词 子宫内膜异位症(EMS) 缩宫素受体(OTR) 子宫结合带 Endometriosis (EMS) Oxytocin receptor (OTR) Uterine junctional zone
  • 相关文献

参考文献7

二级参考文献51

  • 1陈妙研,宋伊丽,周馥贞.IVF-ET中超声参数评价子宫内膜容受性的价值[J].生殖与避孕,2005,25(8):495-499. 被引量:6
  • 2Mechsner S, Grum B, Gericke C, et al.Possible roles of oxytocin receptor and vasopressin-1 c receptor in the pathomechanism of dysperistalsis and dysmenorrhea in patients with adenomyosis uteri[J]. Fertil Steril, 2010, 94 ( 7 ) : 2541-2546.
  • 3Nie J, Liu X, Guo S W.Immunoreactivity of oxytocin receptor and transient receptor potential vanilloid type 1 and its correlation with dysmenorrhea in adenomyosis[J]. Am J Obstet Gynecol, 2010,202( 4 ): 346.
  • 4Spandorfer SD, Goldstein J, Navarro J,et al. Difficult embryotransfer has a negative impact on the outcome of in vitrofertilization. Fertil Steril, 2003,79(3):654-5.
  • 5Bossmar T, Akerlund M,Fantoni G, et al. Receptors for andmyometrial responses to oxytocin and vasopressin in pretermand term human pregnancy: effects of the oxytocin antagonistatosiban. Am J Obstet Gynecol, 1994,171(6):1634-42.
  • 6Akerlund M, Melin P, Maggi M. Potential use of oxytocin andvasopressin Via antagonists in the treatment of preterm la-bor and primary dysmenorrhoea. Adv Exp Med Biol, 1995,395:595-600.
  • 7Pierzynski P,Reinheimer TM, Kuczynski W. Oxytocinantagonists may improve infertility treatment. Fertil Steril,2007,88(l):213.el9-22.
  • 8Lemaster JW, Seals RC, Hopkins FM, et al. Effects ofadministration of oxytocin on embryonic survival in progesto-gen supplemented cattle. Prostaglandins Other Lipid Mediat,1999,57(4):259-68.
  • 9Fanchin R, Righini C, Olivennes F,et al. Uterine contractionsat the time of embryo transfer alter pregnancy rates after invitro fertilization. Hum Reprod, 1998,13(7):1968-74.
  • 10Moon HS, Park HS, Lee JO, et al. Treatment with piroxicambefore embryo transfer increases the pregnancy rate after in-vitro fertilization and embryo transfer. Fertil Steril, 2004,82(4):816-20.

共引文献43

同被引文献81

引证文献12

二级引证文献99

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部